K-V Pharmaceutical And Orphan Drug Makena: Legal Update (12/22/12) ITC Won't Investigate Complaint

Orphan Druganaut Blog has a summary of the events in the trade complaint that K-V Pharmaceutical filed in October 2012 with the US International Trade Commission (ITC). The complaint was an attempt to stop compounding pharmacies from importing 17a hydroxyprogesterone caproate (“HPC”) to unlawfully manufacture copies of orphan drug Makena. The US ITC that it will not investigate the complaint.ad
Read Orphan Druganaut Blog here